CliffBio
small molecule

NIMBEX PRESERVATIVE FREE

CISATRACURIUM BESYLATE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameNIMBEX PRESERVATIVE FREE
Active ingredientCISATRACURIUM BESYLATE
StrengthEQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1995
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NIMBEX PRESERVATIVE FREE patent cliff — loss of exclusivity — | CliffBio